Why I’d buy and hold these ASX 200 blue-chip shares for at least 5 years

When I look at blue-chip ASX 200 shares, I am usually looking for businesses that can keep moving forward over time.

They are the kind that can deal with changing conditions, reinvest sensibly, and still be standing strong years from now.

These three ASX 200 names stand out to me right now for exactly that reason.

Wesfarmers Ltd (ASX: WES)

Wesfarmers is one of those ASX 200 blue-chip shares that can look straightforward on the surface.

It owns well-known retail businesses, such as Kmart, Bunnings, Officeworks, generates solid cash flow, and pays reliable dividends. But I think that simplicity can hide what makes it interesting.

For me, the real strength of Wesfarmers is how it allocates capital.

Over time, the company has reshaped its portfolio, invested in new areas, and exited businesses when the returns are no longer attractive. That kind of discipline is not always easy to find.

Bunnings continues to be the core engine, but there is also a growing focus on areas like lithium, health, and industrial businesses. Not all of these will work perfectly, but I think the approach gives Wesfarmers multiple avenues for growth.

It is that flexibility, combined with a strong base business, that I believe can support steady long-term returns.

Macquarie Group Ltd (ASX: MQG)

Macquarie is very different, but I think it fits the same long-term mindset.

It is often described as an investment bank, but I think that undersells what it has become. Today, it is a global financial services group with exposure to infrastructure, energy, commodities, and asset management.

What I like is its ability to find opportunities in areas that are still evolving. Whether it is renewable energy, infrastructure financing, or asset management, Macquarie tends to position itself where capital is needed and where it can generate attractive returns.

Earnings can be more variable than a traditional bank, and that can lead to volatility in the share price.

But over a five-year period or longer, I think the combination of global exposure and a strong track record of execution gives it a solid foundation for growth.

ResMed Inc. (ASX: RMD)

ResMed brings a different type of exposure again.

It operates in sleep and respiratory care, which I think is one of those areas where demand is likely to keep growing regardless of the economic cycle.

There are long-term drivers here, including ageing populations and increasing awareness of sleep health. These are not trends that disappear quickly.

What I find interesting about ResMed is how it combines that demand with technology. The company is not just selling devices. It is building a connected ecosystem that includes software, data, and patient monitoring.

The share price has had its ups and downs, but I believe the long-term trajectory is up given its leadership position in a large and growing market.

Foolish takeaway

If I am buying ASX 200 blue-chip shares for five years or more, I am looking for are businesses that can adapt, reinvest, and keep building over time.

Wesfarmers, Macquarie, and ResMed each approach that in different ways. For me, that is part of the appeal.

It is not about any single theme. It is about backing quality companies that I believe can keep finding ways to grow.

The post Why I’d buy and hold these ASX 200 blue-chip shares for at least 5 years appeared first on The Motley Fool Australia.

More reading

• 10 excellent ASX shares to buy in May
• Here’s what happened to Wesfarmers shares in April
• Why EQ Resources, Inghams, ResMed, and Skycity shares are tumbling today
• What’s going on with ResMed shares today?
• Resmed reports double-digit revenue and profit increases in Q3 FY26

Motley Fool contributor Grace Alvino has positions in Wesfarmers. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group, ResMed, and Wesfarmers. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.